COVID-KOSHA
Home
Help
(current)
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
Serological survey
Last updated: 2021 Jun 14
Total hit(s): 29
---Sort by---
Key findings ▲
Key findings ▼
Date of publishing ▲
Date of publishing ▼
Citation Count ▲
Citation Count ▼
Impact Factor ▲
Impact Factor ▼
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
In 19205 participants, the
seroprevalence
was <3% until Mid-December 2020 in all regions. Mostly low
seroprevalence
was estimated in Reutlingen, Aachen, Freiburg, and Osnabrück after the first wave while serological study in Magdeburg cumulatively already indicates the onset of the second wave.
Unweighted and weighted SARS-CoV-2 seroprevalences for all study population: Table 5 (https://www.medrxiv.org/content/medrxiv/early/2021/05/06/2021.05.04.21256597/T5/graphic-12.large.jpg and https://www.medrxiv.org/content/medrxiv/early/2021/05/06/2021.05.04.21256597/T5/graphic-13.large.jpg)
✍
Pre-print
(
bioRXiv
)
Date of Publishing
2021 May 6
Title
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions
Author(s) name
Manuela Harries
Impact factor
N/A
Date of Entry
2021 Jun 14
Serological survey of mild/asymptomatic SARS-CoV-2 infected individuals were tested with three immunoassays.
Antibodies
were found to be present for atleast 8 months after infection.
No comments
✍
Pre-print
(
medRXiv
)
Title
Serological survey of mild/asymptomatic SARS-CoV-2 infected individuals were tested with three immunoassays. Antibodies were found to be present for atleast 8 months after infection.
Author(s) name
-
Impact factor
N/A
Date of Entry
2021 Jun 14
Serological survey of mild/asymptomatic SARS-CoV-2 infected individuals were tested with three immunoassays.
Antibodies
were found to be present for atleast 8 months after infection.
No comments
✍
Pre-print
(
medRXiv
)
Title
Persistence and detection of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
Author(s) name
-
Impact factor
N/A
Date of Entry
2021 Jun 14
Out of 30 COVID
-S*
19 patients, 23 showed the presence of anti
-S*
N
antibodies,
20 showed anti
-S*
**
antibodies,
and 13 had anti
-S*
M
antibodies.
S** denotes a full-length spike with a pair of trimer-stabilizing proline mutations (986KV987 to 986PP987) and a quartet of S1/S2 protease cleavage site changes (682RRAR685 to 682GSAG685)
✍
33330866
(
bioRxiv
)
PMID
33330866
Date of Publishing
: 2020 Dec 9
Title
The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike
Author(s) name
Guo C, Tsai SJ et al.
Journal
bioRxiv
Impact factor
- n/a -
Citation count
: 3
×
NLM format
Guo C, Tsai SJ, Ai Y, Li M, Pekosz A, Cox A, Atai N, Gould SJ. The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike. bioRxiv. 2020 Dec 9:2020.12.08.417022. PMID:33330866
Out of 10,449 Healthcare professionals, 136 showed
seropositivity
for SARS-COV-2 lgG . Among 136, 70% showed symptoms like
Cough
(23.2%),
Headache
(22.1%) and
Fatigue
(21.1%).
✍
33292895
(
Infect Control Hosp Epidemiol
)
PMID
33292895
Date of Publishing
: 2020 Dec 9
Title
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic
Author(s) name
Rosser JI, Röltgen K et al.
Journal
Infect Control Hosp Epidemiol
Impact factor
2.66
Citation count
: 7
×
NLM format
Rosser JI, Röltgen K, Dymock M, Shepard J, Martin A, Hogan CA, Blomkalns A, Mathew R, Parsonnet J, Pinsky BA, Maldonado YA, Boyd SD, Chang SI, Holubar M; Stanford Healthcare COVID-19 Workforce Response Group. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2020 Dec 9:1-7. PMID:33292895
Out of 1686 individuals in
Germany,
46 (2.7%) were
seropositive
for anti-SARS-CoV-2 IgG
antibodies.
✍
33339986
(
Nat Rev Rheumatol
)
PMID
33339986
Date of Publishing
: 2020 Dec 18
Title
Rheumatic disease and COVID-19: epidemiology and outcomes
Author(s) name
Hyrich KL, Machado PM.
Journal
Nat Rev Rheumatol
Impact factor
16
Citation count
: 45
×
NLM format
Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021 Feb;17(2):71-72. PMID:33339986
Out of 790 participants in an University student population, estimated
seroprevalence
of Anti-SARS-CoV-2 IgG
antibodies
was 4%. This indicated that the prevalence of infection/SARS-COV-2
antibodies
in a University population was similar to the community
seroprevalence.
✍
33071164
(
J Adolesc Health
)
PMID
33071164
Date of Publishing
: 2020 Dec
Title
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population
Author(s) name
Tilley K, Ayvazyan V et al.
Journal
J Adolesc Health
Impact factor
6.3
Citation count
: 18
×
NLM format
Tilley K, Ayvazyan V, Martinez L, Nanda N, Kawaguchi ES, O'Gorman M, Conti D, Gauderman WJ, Van Orman S. A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population. J Adolesc Health. 2020 Dec;67(6):763-768. PMID:33071164
Out of 7361 individuals in
Netherlands,
200 (2.7%) were
seropositive.
Antibodies
were more significantly detected in younger people of 18-30 years age group (4.2%) compared to older people of 61-72 years age group (2.7%).
✍
33184284
(
Nat Commun
)
PMID
33184284
Date of Publishing
: 2020 Nov 12
Title
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
Author(s) name
Slot E, Hogema BM et al.
Journal
Nat Commun
Impact factor
11.8
Citation count
: 35
×
NLM format
Slot E, Hogema BM, Reusken CBEM, Reimerink JH, Molier M, Karregat JHM, IJlst J, NovotnĂ˝ VMJ, van Lier RAW, Zaaijer HL. Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands. Nat Commun. 2020 Nov 12;11(1):5744. PMID:33184284
Out of 1122 participants in an Indian Tertiary care hospital, overall
seroprevalence
for SARS-CoV-2 IgG
antibodies
was 11.94% of which 19.85% of High risk healthcare workers, 11.09% of Intermediate risk Healthcare workers and 8% of Low risk healthcare workers were
seropositive
.
✍
33187030
(
J Assoc Physicians India
)
PMID
33187030
Date of Publishing
: 2020 Nov
Title
Seroprevalence of COVID-19 amongst Health care workers in a Tertiary Care Hospital of a Metropolitan City from India
Author(s) name
Goenka M, Afzalpurkar S et al.
Journal
J Assoc Physicians India
Impact factor
0.5
Citation count
: 25
×
NLM format
Goenka M, Afzalpurkar S, Goenka U, Das SS, Mukherjee M, Jajodia S, Shah BB, Patil VU, Rodge G, Khan U, Bandyopadhyay S. Seroprevalence of COVID-19 amongst Health care workers in a Tertiary Care Hospital of a Metropolitan City from India. J Assoc Physicians India. 2020 Nov;68(11):14-19.. PMID:33187030
Among the healthworkers under study, majority were
seronegative
indicating lack of
antibodies
to SARS-CoV-2.
✍
33033249
(
Nat Commun
)
PMID
33033249
Date of Publishing
: 2020 Oct 8
Title
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Author(s) name
Rudberg AS, Havervall S et al.
Journal
Nat Commun
Impact factor
11.8
Citation count
: 135
×
NLM format
Rudberg AS, Havervall S, Månberg A, Jernbom Falk A, Aguilera K, Ng H, Gabrielsson L, Salomonsson AC, Hanke L, Murrell B, McInerney G, Olofsson J, Andersson E, Hellström C, Bayati S, Bergström S, Pin E, Sjöberg R, Tegel H, Hedhammar M, Phillipson M, Nilsson P, Hober S, Thålin C. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020 Oct 8;11(1):5064. PMID:33033249
Out of 1215 recovered persons and 4222 quarantined persons,1107 (91.1%) and 97 (2.3%) were
seropositive,
respectively.
✍
32871063
(
N Engl J Med
)
PMID
32871063
Date of Publishing
: 2020 Oct 29
Title
Humoral Immune Response to SARS-CoV-2 in Iceland
Author(s) name
Gudbjartsson DF, Norddahl GL et al.
Journal
N Engl J Med
Impact factor
37.91
Citation count
: 465
×
NLM format
Gudbjartsson DF, Norddahl GL, Melsted P, Gunnarsdottir K, Holm H, Eythorsson E, Arnthorsson AO, Helgason D, Bjarnadottir K, Ingvarsson RF, Thorsteinsdottir B, Kristjansdottir S, Birgisdottir K, Kristinsdottir AM, Sigurdsson MI, Arnadottir GA, Ivarsdottir EV, Andresdottir M, Jonsson F, Agustsdottir AB, Berglund J, Eiriksdottir B, Fridriksdottir R, Gardarsdottir EE, Gottfredsson M, Gretarsdottir OS, Gudmundsdottir S, Gudmundsson KR, Gunnarsdottir TR, Gylfason A, Helgason A, Jensson BO, Jonasdottir A, Jonsson H, Kristjansson T, Kristinsson KG, Magnusdottir DN, Magnusson OT, Olafsdottir LB, Rognvaldsson S, le Roux L, Sigmundsdottir G, Sigurdsson A, Sveinbjornsson G, Sveinsdottir KE, Sveinsdottir M, Thorarensen EA, Thorbjornsson B, Thordardottir M, Saemundsdottir J, Kristjansson SH, Josefsdottir KS, Masson G, Georgsson G, Kristjansson M, Moller A, Palsson R, Gudnason T, Thorsteinsdottir U, Jonsdottir I, Sulem P, Stefansson K. Humoral Immune Response to SARS-CoV-2 in Iceland. N Engl J Med. 2020 Oct 29;383(18):1724-1734. PMID:32871063
Seroconversion
of SARS-CoV-2 in people living with HIV (PLWH) on stable ART occurred similarly to that in non-HIV-infected patients.
✍
33046418
(
J Microbiol Immunol Infect
)
PMID
33046418
Date of Publishing
: 2020 Oct 2
Title
Antibody response to SARS-CoV-2 in people living with HIV.
Author(s) name
Yamamoto S, Saito M et al.
Journal
J Microbiol Immunol Infect
Impact factor
2.33
Citation count
: 8
×
NLM format
Yamamoto S, Saito M, Nagai E, Toriuchi K, Nagai H, Yotsuyanagi H, Nakagama Y, Kido Y, Adachi E. Antibody response to SARS-CoV-2 in people living with HIV.. J Microbiol Immunol Infect. 2021 Feb;54(1):144-146. PMID:33046418
Out of 291 participants in long term facilities, including 122 residents and 169 staff, 113 were
sero-reactive
and 178 were non-reactive.
✍
33086096
(
Am J Infect Control
)
PMID
33086096
Date of Publishing
: 2020 Oct 18
Title
Serological survey following SARS-COV-2 outbreaks at long term care facilities in netro Vancouver, British Columbia: Implications for outbreak management and infection control policies
Author(s) name
Vijh R, Ghafari C et al.
Journal
Am J Infect Control
Impact factor
2.03
Citation count
: 5
×
NLM format
Vijh R, Ghafari C, Hayden A, Schwandt M, Sekirov I, Morshed M, Levett P, Krajden M, Boraston S, Daly P, Lysyshyn M, Harding J, McLennan M, Chahil N, Mak A, McKee G. Serological survey following SARS-COV-2 outbreaks at long term care facilities in netro Vancouver, British Columbia: Implications for outbreak management and infection control policies. Am J Infect Control. 2021 May;49(5):649-652. PMID:33086096
Out of 5391 participants, a
seropositivity
rate of 61.2% for
IgM,
58.8% for
IgG
and 62.1% for IgM/IgG in COVID-19 confirmed cases,
seropositivity
rate of 29% for
IgM,
37% for
IgG,
55% for both IgM/IgG in suspected cases and 19% for IgM/IgG in
asymptomatic
cases were observed.
✍
33090430
(
Eur Rev Med Pharmacol Sci
)
PMID
33090430
Date of Publishing
: 2020 Oct
Title
Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies
Author(s) name
Guo CC, Mi JQ, Nie H.
Journal
Eur Rev Med Pharmacol Sci
Impact factor
2.51
Citation count
: 8
×
NLM format
Guo CC, Mi JQ, Nie H. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies. Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10208-10218. PMID:33090430
Out of 464 healthcare workers, 809 industrial employees and 402 community members in Karachi,
Pakistan,
13%, 50.3% and 34%, were
seropositive
respectively. Overall
seroprevalence
rate was 36%.
✍
32940328
(
J Public Health (Oxf)
)
PMID
32940328
Date of Publishing
: 2020 Sep 17
Title
Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi - Challenges in acquiring herd immunity for COVID-19
Author(s) name
Zaidi S, Rizwan F et al.
Journal
J Public Health (Oxf)
Impact factor
1.55
Citation count
: 10
×
NLM format
Zaidi S, Rizwan F, Riaz Q, Siddiqui A, Khawaja S, Imam M, Naz A, Waheed S, Shamsi T. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi - Challenges in acquiring herd immunity for COVID-19. J Public Health (Oxf). 2021 Apr 12;43(1):3-8. PMID:32940328
Out of 51958 participants in
Spain,
overall
seroprevalence
rate was 4.6% using Chemiluminescence immunoassay. Out of 4.6%, patients with positive PCR status greater than 14 days showed 90.1%
seroprevalence
rate.
✍
32645347
(
Lancet
)
PMID
32645347
Date of Publishing
: 2020 Aug 22
Title
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Author(s) name
Pollán M, Pérez-Gómez B et al.
Journal
Lancet
Impact factor
43.38
Citation count
: 813
×
NLM format
Pollán M, PĂ©rez-GĂłmez B, Pastor-Barriuso R, Oteo J, Hernán MA, PĂ©rez-Olmeda M, SanmartĂn JL, Fernández-GarcĂa A, Cruz I, Fernández de Larrea N, Molina M, RodrĂguez-Cabrera F, MartĂn M, Merino-Amador P, LeĂłn Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R; ENE-COVID Study Group. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.. Lancet. 2020 Aug 22;396(10250):535-544. PMID:32645347
Out of 61075 participants in
Spain,
overall
seroprevalence
rate was 5% using Point rapid care testing. Out of 5% ,patients with positive PCR status greater than 14 days showed 88.6%
seroprevalence
rate.
✍
32645347
(
Lancet
)
PMID
32645347
Date of Publishing
: 2020 Aug 22
Title
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Author(s) name
Pollán M, Pérez-Gómez B et al.
Journal
Lancet
Impact factor
43.38
Citation count
: 813
×
NLM format
Pollán M, PĂ©rez-GĂłmez B, Pastor-Barriuso R, Oteo J, Hernán MA, PĂ©rez-Olmeda M, SanmartĂn JL, Fernández-GarcĂa A, Cruz I, Fernández de Larrea N, Molina M, RodrĂguez-Cabrera F, MartĂn M, Merino-Amador P, LeĂłn Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R; ENE-COVID Study Group. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.. Lancet. 2020 Aug 22;396(10250):535-544. PMID:32645347
Seroprevalence
estimates for 5 weeks did not show much difference after 1st week of the study.
✍
32534626
(
Lancet
)
PMID
32534626
Date of Publishing
: 2020 Aug 1
Title
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Author(s) name
Stringhini S, Wisniak A et al.
Journal
Lancet
Impact factor
43.38
Citation count
: 449
×
NLM format
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, GĂ©taz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 Aug 1;396(10247):313-319. PMID:32534626
Out of 17368 participants, cumulative
seroprevalence
of
IgM
and
IgG
was reported as 44% and 56%, respectively.
✍
32504052
(
Nat Med
)
PMID
32504052
Date of Publishing
: 2020 Aug
Title
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
Author(s) name
Xu X, Sun J et al.
Journal
Nat Med
Impact factor
22.66
Citation count
: 187
×
NLM format
Xu X, Sun J, Nie S, Li H, Kong Y, Liang M, Hou J, Huang X, Li D, Ma T, Peng J, Gao S, Shao Y, Zhu H, Lau JY, Wang G, Xie C, Jiang L, Huang A, Yang Z, Zhang K, Hou FF. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med. 2020 Aug;26(8):1193-1195. PMID:32504052
Out of 1293 parturient women in Philadelphia, 80 (6.2%) had
IgG
and/or
IgM
SARS-CoV-2specific
antibodies.
The
seropositivity
was higher in Black/non-Hispanic and Hispanic/Latino women compared to Asian and White/non-Hispanic women.
✍
32727884
(
Sci Immunol
)
PMID
32727884
Date of Publishing
: 2020 Jul 29
Title
SARS-CoV-2 seroprevalence among parturient women in Philadelphia
Author(s) name
Flannery DD, Gouma S et al.
Journal
Sci Immunol
Impact factor
8.16
Citation count
: 66
×
NLM format
Flannery DD, Gouma S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Woodford EC, Gerber JS, Arevalo CP, Bolton MJ, Weirick ME, Goodwin EC, Anderson EM, Greenplate AR, Kim J, Han N, Pattekar A, Dougherty J, Kuthuru O, Mathew D, Baxter AE, Vella LA, Weaver J, Verma A, Leite R, Morris JS, Rader DJ, Elovitz MA, Wherry EJ, Puopolo KM, Hensley SE. SARS-CoV-2 seroprevalence among parturient women in Philadelphia. Sci Immunol. 2020 Jul 29;5(49):eabd5709. PMID:32727884
Out of 1914
serum
samples from 35 species of animals, none of them were
seropositive.
✍
32303108
(
Transbound Emerg Dis
)
PMID
32303108
Date of Publishing
: 2020 Jul
Title
Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals
Author(s) name
Deng J, Jin Y et al.
Journal
Transbound Emerg Dis
Impact factor
3.47
Citation count
: 62
×
NLM format
Deng J, Jin Y, Liu Y, Sun J, Hao L, Bai J, Huang T, Lin D, Jin Y, Tian K. Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals. Transbound Emerg Dis. 2020 Jul;67(4):1745-1749. PMID:32303108
Out of 1071 samples, 41 samples were SARS-CoV-2
IgG
positive with a proportion of 3.83%, including 4.8% in central metropolitan Tokyo, 1.6% in suburban Tokyo and the highest 7.92% in the southern areas of central Tokyo.
✍
32674696
(
J Prim Care Community Health
)
PMID
32674696
Date of Publishing
: 2020 Jan-Dec
Title
Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care ClinicBased Point-of-Care Antibody Testing
Author(s) name
Takita M, Matsumura T et al.
Journal
J Prim Care Community Health
Impact factor
1.4
Citation count
: 10
×
NLM format
Takita M, Matsumura T, Yamamoto K, Yamashita E, Hosoda K, Hamaki T, Kusumi E. Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care ClinicBased Point-of-Care Antibody Testing. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720942695. PMID:32674696
Out of 1071 patient samples in Tokyo, 41 (3.83%) samples were SARS-CoV-2
IgG
positive including a
seroprevalence
rate of 4.8% in Central metropolitan Tokyo, 1.6% in suburban Tokyo and the highest rate of 7.92% in the southern areas of central Tokyo.
✍
32674696
(
J Prim Care Community Health
)
PMID
32674696
Date of Publishing
: 2020 Jan-Dec
Title
Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic-Based Point-of-Care Antibody Testing
Author(s) name
Takita M, Matsumura T et al.
Journal
J Prim Care Community Health
Impact factor
1.4
Citation count
: 10
×
NLM format
Takita M, Matsumura T, Yamamoto K, Yamashita E, Hosoda K, Hamaki T, Kusumi E. Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic-Based Point-of-Care Antibody Testing. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720942695. PMID:32674696
Out of 200 children in Prague, 2 were
seropositive
(<0.5%) which was comparatively lesser than overall
seroprevalence
(1.3%).
Median age of the children in the study was 9 years.
✍
33304869
(
Front Pediatr
)
PMID
33304869
Date of Publishing
: 2020
Title
Searching for COVID-19 Antibodies in Czech ChildrenA Needle in the Haystack
Author(s) name
Bloomfield M, Pospisilova I et al.
Journal
Front Pediatr
Impact factor
2.46
Citation count
: 2
×
NLM format
Bloomfield M, Pospisilova I, Cabelova T, Sediva A, Ibrahimova M, Borecka K, Magner M. Searching for COVID-19 Antibodies in Czech ChildrenA Needle in the Haystack. Front Pediatr. 2020 Nov 12;8:597736. PMID:33304869
Out of 2906 individuals tested for SARS-CoV-2 IgG
antibodies,
111 (3.8%) were
seropositive.
14 (10.4%) out of 135
symptomatic
and 97 (3.5%) out of 2771
asymptomatic
patients were IgG
seropositive.
✍
33175878
(
PLoS One
)
PMID
33175878
Date of Publishing
: 2020
Title
Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross- sectional study
Author(s) name
Khan SMS, Qurieshi MA et al.
Journal
PLoS One
Impact factor
2.87
Citation count
: 11
×
NLM format
Khan SMS, Qurieshi MA, Haq I, Majid S, Bhat AA, Nabi S, Ganai NA, Zahoor N, Nisar A, Chowdri IN, Qazi TB, Kousar R, Lone AA, Sabah I, Nabi S, Sumji IA, Kawoosa MF, Ayoub S. Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross- sectional study. PLoS One. 2020 Nov 11;15(11):e0239303. PMID:33175878